Pages that link to "Q52176922"

The following pages link to Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases. (Q52176922):

Displaying 23 items.

• Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization (Q28191605) (← links)
• A biphasic and brain-region selective down-regulation of cyclic adenosine monophosphate concentrations supports object recognition in the rat (Q28480922) (← links)
• Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes. (Q30478804) (← links)
• PDE4 cAMP-specific phosphodiesterases (Q34364468) (← links)
• Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats (Q34433189) (← links)
• Effect of rolipram, a phosphodiesterase enzyme type-4 inhibitor, on γ-amino butyric acid content of the frontal cortex in mice exposed to chronic mild stress (Q35975217) (← links)
• Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus (Q37346336) (← links)
• Dual inhibitors of phosphodiesterase-4 and serotonin reuptake (Q37388604) (← links)
• Zaprinast, a phosphodiesterase type-5 inhibitor, alters paced mating behavior in female rats (Q37398011) (← links)
• Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System (Q37561575) (← links)
• Differential function of phosphodiesterase families in the brain: gaining insights through the use of genetically modified animals (Q37714967) (← links)
• The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice (Q42461221) (← links)
• Downregulation of fasting-induced cAMP response element-mediated gene induction by leptin in neuropeptide Y neurons of the arcuate nucleus. (Q42498547) (← links)
• Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study (Q44264543) (← links)
• Antidepressant-like effects of PDE4 inhibitors mediated by the high-affinity rolipram binding state (HARBS) of the phosphodiesterase-4 enzyme (PDE4) in rats (Q44918715) (← links)
• The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior induced by cues or heroin priming in rats (Q44998208) (← links)
• Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats (Q45239418) (← links)
• Increased particulate phosphodiesterase 4 in the prefrontal cortex supports 5-HT4 receptor-induced improvement of object recognition memory in the rat. (Q46423033) (← links)
• The PDE4 cAMP-Specific Phosphodiesterases: Targets for Drugs with Antidepressant and Memory-Enhancing Action (Q47732733) (← links)
• The novel long PDE4A10 cyclic AMP phosphodiesterase shows a pattern of expression within brain that is distinct from the long PDE4A5 and short PDE4A1 isoforms (Q48700597) (← links)
• Development of rolipram-sensitive, cyclic AMP phosphodiesterase (PDE4) in rat primary neuronal cultures (Q48792547) (← links)
• Association study of PDE4B with panic disorder in the Japanese population (Q48942658) (← links)
• Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain (Q73850613) (← links)